Capricorn Partners

Capricorn Partners is an independent asset manager based in Belgium, established in 1993. The firm specializes in managing venture capital funds that focus on investing in innovative European companies leveraging technology as a competitive advantage. Its investment team consists of experienced managers with extensive expertise in technology and a broad range of industrial experience. Capricorn Partners aims to foster the growth of technology-based companies across Europe, enhancing their potential through strategic investments.

Jan Avonts

Investment Manager

Daniela Arruda Costa

Investment Associate

Olaf Cörper

Partner

Antoine D’Hollander

Investment Associate

Paul van Eynde

Senior Investment Manager

Katrin Geyskens

Partner

Yvette Go

Investment Director

Ludwig Goris

Senior Investment Manager

Steven Lambert

Senior Investment Manager

Maarten Lambert

Senior Associate

Marc Lambrechts

Investment Director

Steven Levecke

Senior Investment Manager

Jos B. Peeters

Managing Partner

Wouter Van de Putte

Investment Associate

Katya Smirnyagina

Executive Director CHF

Ekaterina Smirnyagina

Partner

Claude J. Stoufs

Partner

Yves Vaneerdewegh

Partner

Els Vanheusden

Senior Investment Manager

88 past transactions

Chainels

Series A in 2023
CHAINels is a web based Business Platform providing a tailored communication and management tool for groups of SMEs. CHAINels offers an integral and low-cost solution to consolidate and facilitate communication between Business Interest group members, group management and the outside world. Using the most recent technology, CHAINels provides its customers with advanced tools to drastically increase the economic value of their Business Interest group. CHAINels platform is a fully web-based alternative to SAAS and Intranet custom made tools aimed at business interest groups. CHAINels aims to build a single environment offering both Intranet and Internet benefits to its users. The services are delivered through web-based platform for organizations, business groups, and companies where they can connect and interact with each other by establishing mutual links (chains). For business groups sharing the same interest, CHAINels offers tailored management, communication and identity maintenance solutions. For group members – the SMEs, the platform becomes a vessel of on line business presence, combining the functionality of a dynamic business directory with traits of a traditional business network.

Gradyent

Series A in 2022
Gradyent B.V. designs and develops cloud-based artificial intelligence (AI) software that supports the management and optimization of district heating networks. Its platform uses digital twin technology that uses combination of hydro and thermodynamic modeling with AI to optimize and forecast the heating network in real time and detect any changes in it. The company primarily caters to district heating companies. Gradyent B.V. was founded in 2019 and is based in Utrecht, the Netherlands with research and development centre in The Hague, the Netherlands.

StoryChief

Venture Round in 2022
StoryChief.io is a content marketing software designed for startups, SEO marketers, and editorial teams seeking to streamline their content creation and distribution processes. The platform enables users to publish stories across multiple channels, including WordPress, Medium, newsletters, and various social media platforms, all from a single interface. Its universal editor allows for the easy creation of visually appealing articles tailored for different publishing formats. Additionally, StoryChief offers features such as SEO suggestions, performance tracking, and lead capture integration with CRM systems, helping users measure their impact and return on investment effectively. By centralizing content management, StoryChief enhances the reach and efficiency of content marketing efforts.

Finquest

Seed Round in 2022
Finquest is an M&A and direct investments platform for middle-market opportunities in Asia. The platform delivers targeted and actionable introductions through its database of 650,000 organizations, proprietary algorithm, and team of professionals. Finquest enables its clients to source new investment opportunities in Asia, identify relevant institutional investors and acquirers, and more. It was launched by Antoine Denaiffe, Tanguy Lesselin, Gerard Belicha, and Jerome Pinneau in 2016.

Zozio

Seed Round in 2022
Developer of a digital companion designed for industrial operators based on AI algorithms. The company's platform intends to change the way people work in the factory by creating Factory 4.0 and collecting, visualizing, and analyzing field data in real-time within the industrial site and outside making the factory more efficient, improving the working conditions of the operators and minimizing the waste of resources, enabling supply chain of manufacturers to improve their competitiveness on an international scale.

Black Bear Carbon

Venture Round in 2021
Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

EclecticIQ

Series C in 2020
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Sensolus

Venture Round in 2020
Sensolus NV designs and develops global positioning system (GPS) trackers that allows to track non-powered assets. It offers turnkey solutions for wireless and low-power context-aware sensing. The company also provides a web based platform, Internet of things (IoT) cloud platform, and application that helps to provide real time information about assets. It serves manufacturing, waste management, cargo transport, transport and logistics, and automotive industry. The company was founded in 2013 and is based in Ghent, Belgium.

EclecticIQ

Series C in 2020
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Innovium

Series F in 2020
Innovium, Inc. develops and deploys switching silicon solutions for cloud, enterprise, and edge data centers in the United States and internationally. It offers TERALYNX 7 for large scale public and private cloud; and TERALYNX 5 for ToR, enterprise, Edge, and 5G data centers. The company also provides Network OS, a cloud, OEM, open-source network operating system; open source and standard APIs; and TERALYNX software development kit. Innovium, Inc. was incorporated in 2014 and is headquartered in San Jose, California with a location in Bengaluru, India.

Gradyent

Seed Round in 2020
Gradyent B.V. designs and develops cloud-based artificial intelligence (AI) software that supports the management and optimization of district heating networks. Its platform uses digital twin technology that uses combination of hydro and thermodynamic modeling with AI to optimize and forecast the heating network in real time and detect any changes in it. The company primarily caters to district heating companies. Gradyent B.V. was founded in 2019 and is based in Utrecht, the Netherlands with research and development centre in The Hague, the Netherlands.

Virovet

Series B in 2020
ViroVet NV develops virus control solutions for the livestock industry. It offers antiviral drugs for the control and treatment of respiratory diseases of cattle and swine. The company also offers modified live virus vaccines for endemic and epizootic viral livestock diseases. ViroVet NV was founded in 2015 and is based in Leuven, Belgium.

VOID Technologies

Venture Round in 2020
VOID Technologies Limited is a materials science company based in London, United Kingdom, with a manufacturing facility in Neenah, Wisconsin. Established in 2014, VOID Technologies specializes in the production and supply of VO+ additive masterbatches, which are utilized by film manufacturers across various applications, including labels, food packaging, bags, snacks, tapes, and strapping. The company emerged as a spin-out from Kimberly-Clark Corporation, aiming to commercialize the innovative VO+ technology. As a subsidiary of Kimberly-Clark, VOID Technologies is positioned to leverage its parent company's expertise while focusing on the advancement of sustainable materials in the packaging industry.

Prolupin

Venture Round in 2020
Prolupin GmbH is a spin-off from the Fraunhofer Institute for Process Engineering and Packaging IVV in Freising. The world-leading expertise on the fractionation of lupines and the application of this in food technology gives the business a strong position in the vegetable protein market. This position is secured by several Fraunhofer patents. The company's business activities focus on developing, producing and marketing vegetable-based, lactose-free milk substitutes from the blue sweet lupine (Lupinus angustifolius). This domestic legume is particularly rich in proteins, undemanding with regard to soil and climate and grows predominantly in Northern Germany (soybean of the north), Poland, Scandinavia, North America and Australia. With the processing technologies developed at Fraunhofer IVV, it is possible to adapt the lupine protein flavor profile in such a way as to achieve a milk-like taste.

DMC

Series A in 2019
DMC Biotechnologies, Inc., a biotechnology company, develops bio-based products using microbial fermentation technology. The company's technology for engineering of microbial hosts enables the production of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. It develops and deploys Dynamic Metabolic Control technology that reduces the cost and development timeline from discovery to commercial performance. DMC Biotechnologies, Inc. was founded in 2017 and is based in Boulder, Colorado.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Arkite NV

Venture Round in 2019
Arkite NV manufactures automation products, Human Interface Mate, which assists the manufacturing operator by warning as soon as a wrong operation is in progress and navigates towards standardized work. The company was founded in 2015 and is based in Genk, Belgium.

icometrix

Series A in 2019
Icometrix develops automated magnetic resonance imaging (MRI) biomarkers. The company offers icobrain ms that track disease progression in individual multiple sclerosis patients; cobrain dm that quantifies brain structures in individual dementia patients; and icobrain tbi, which tracks axonal injuries in individual head trauma patients. It also provides services in the areas of CT and advanced MRI. The company is based in Leuven, Belgium.

Confo Therapeutics

Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO® technology, Confo Therapeutics stabilizes inherently unstable functional conformations of GPCRs, providing a robust starting point for drug discovery. This approach reveals previously inaccessible structural features of these receptors, facilitating the identification of novel agonists that enhance therapeutic interventions.

Miaa Guard

Venture Round in 2019
miaa Guard CVBA develops a platform that implements access control solutions to monetise digital business with microservice APIs. The platform offers API and introduces a access model to respond to identities of consumers and professionals within an enterprise's context, access rights and policies for an enterprise's digital assets, and authorisations granted by users to other users. It provides services, including security and access governance; integration and data architecture; and configuration and customisation. miaa Guard CVBA was formerly known as VintiQ and changed its name to miaa Guard CVBA in 2014. The company was founded in 2009 and is based in Leuven, Belgium.

Black Bear Carbon

Venture Round in 2018
Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

c-LEcta

Venture Round in 2018
c-LEcta GmbH operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. The company develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. It offers DENARASE, a genetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. c-LEcta GmbH was founded in 2004 and is based in Leipzig, Germany.

Nexstim

Post in 2018
Nexstim Plc is a neuromodulation company based in Helsinki, Finland, that develops and markets non-invasive brain stimulation technologies. The company specializes in image-guided transcranial magnetic stimulation (TMS) through its proprietary SmartFocus technology, which features 3D navigation for both therapeutic and diagnostic purposes. Nexstim offers the NBT system, designed to treat major depressive disorder and chronic neuropathic pain, as well as the NBS system, which is utilized for pre-surgical mapping of the brain's speech and motor cortices. Primarily, the NBS systems are sold to universities and teaching hospitals. Founded in 2000, Nexstim aims to enhance the quality of life for patients with significant unmet clinical needs through its innovative approaches to brain therapy.

LindaCare

Series B in 2018
LindaCare Ltd. is based in Leuven, Belgium, and specializes in developing a tele-monitoring dashboard for data from various cardiac implantable device vendors. The platform integrates seamlessly with electronic patient records, enhancing workflow automation and efficiency while offering customizable alerts across different vendors to minimize medical errors. LindaCare aims to reduce the cost and improve the quality of care in chronic disease management by providing healthcare professionals and hospitals with a unified, vendor-independent software solution. This approach simplifies patient tele-monitoring, ultimately enhancing patient safety and the overall quality of care.

DMC

Seed Round in 2018
DMC Biotechnologies, Inc., a biotechnology company, develops bio-based products using microbial fermentation technology. The company's technology for engineering of microbial hosts enables the production of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. It develops and deploys Dynamic Metabolic Control technology that reduces the cost and development timeline from discovery to commercial performance. DMC Biotechnologies, Inc. was founded in 2017 and is based in Boulder, Colorado.

NGDATA

Series C in 2017
NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.

Arkite NV

Venture Round in 2017
Arkite NV manufactures automation products, Human Interface Mate, which assists the manufacturing operator by warning as soon as a wrong operation is in progress and navigates towards standardized work. The company was founded in 2015 and is based in Genk, Belgium.

Sensolus

Seed Round in 2017
Sensolus NV designs and develops global positioning system (GPS) trackers that allows to track non-powered assets. It offers turnkey solutions for wireless and low-power context-aware sensing. The company also provides a web based platform, Internet of things (IoT) cloud platform, and application that helps to provide real time information about assets. It serves manufacturing, waste management, cargo transport, transport and logistics, and automotive industry. The company was founded in 2013 and is based in Ghent, Belgium.

Virovet

Series A in 2017
ViroVet NV develops virus control solutions for the livestock industry. It offers antiviral drugs for the control and treatment of respiratory diseases of cattle and swine. The company also offers modified live virus vaccines for endemic and epizootic viral livestock diseases. ViroVet NV was founded in 2015 and is based in Leuven, Belgium.

FEops

Series B in 2017
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians. Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

NGDATA

Series B in 2017
NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.

Indigo Diabetes

Series A in 2016
Indigo Diabetes nv is a medical device company based in Ghent, Belgium, founded in 2016 by Danaë Delbeke and her team. The company specializes in developing an innovative invisible glucose monitor that utilizes advanced photonics technology to measure and manage blood glucose levels without the need for finger pricks. This high-tech sensor is designed to be inserted under the skin, allowing for continuous monitoring of blood sugar levels. Indigo Diabetes aims to enhance the user experience for individuals living with diabetes by providing a more accurate and convenient method for glucose monitoring, thereby transforming diabetes management.

Noona Healthcare

Seed Round in 2016
Noona is a mobile service that provides cancer centers a real-time holistic view of their patients’ wellbeing. Noona improves the quality of cancer patient care and makes the patient-clinic relationship more personal and meaningful. Clinical staff can rapidly respond to severe symptoms and provide better care to far greater numbers of patients. Noona also enables patients to follow their own wellbeing and recovery and stay in close contact with their clinic.

FRX Innovations

Series D in 2016
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

Diagenode

Venture Round in 2016
Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country. Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Epigenetics Division

iSTAR Medical

Series B in 2016
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Bluebee

Series A in 2016
Bluebee Holding B.V. develops cloud-based accelerated genomics analysis platform that enables processing of sequencing data. The company’s Bluebee genomics platform supports cross-functional teams of life science researchers and clinicians in processing, managing, and sharing sequence data. The company also offers data analytics and aggregation and customized user experience. It serves research centers, sequencing service providers, clinical labs, and kit providers. The company was founded in 2011 and is based in Rijswijk, the Netherlands. As of June 17, 2020, Bluebee Holding B.V. operates as a subsidiary of Illumina, Inc.

LindaCare

Series A in 2015
LindaCare Ltd. is based in Leuven, Belgium, and specializes in developing a tele-monitoring dashboard for data from various cardiac implantable device vendors. The platform integrates seamlessly with electronic patient records, enhancing workflow automation and efficiency while offering customizable alerts across different vendors to minimize medical errors. LindaCare aims to reduce the cost and improve the quality of care in chronic disease management by providing healthcare professionals and hospitals with a unified, vendor-independent software solution. This approach simplifies patient tele-monitoring, ultimately enhancing patient safety and the overall quality of care.

NGDATA

Series B in 2015
NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.

Sequana Medical

Series C in 2015
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.

Ogeda

Series B in 2015
Ogeda SA, a clinical-stage drug discovery company, invents and develops small molecule drugs targeting G-Protein Coupled Receptors. It offers fezolinetant (ESN364), a Phase II clinical development product for the treatment of women’s health disorders; NK3 antagonists for the treatment of hormone-dependent pathologies in women's health; and products for endocrine, CNS/inflammatory disorders. Ogeda SA was formerly known as Euroscreen SA and changed its name to Ogeda SA in October 2016. The company was founded in 1994 and is based in Gosselies, Belgium. It has a meeting facility in Brussels, Belgium; and an additional office in Paris, France. Ogeda SA operates as a subsidiary of Astellas Pharma Inc.

NovoPolymers

Venture Round in 2015
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

FEops

Series A in 2015
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians. Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

Green Biologics

Series C in 2015
Green Biologics is a revenue generating industrial biotech company based in Oxfordshire aiming to become the world's leading supplier of advanced fermentation technologies for conversion of biomass to renewable fuels and chemicals.

SpaceX

Series G in 2015
Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs, manufactures, and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusable launch vehicles Falcon 1 and Falcon 9. Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California.

Avantium

Series G in 2014
Avantium is a technology company based in Amsterdam, specializing in advanced high-throughput research and development for the energy, chemicals, and pharmaceutical sectors. It employs proprietary technology that accelerates and reduces the costs associated with developing new products and processes. Avantium's innovative approach to experiment design and data analysis enhances its success rate in delivering effective solutions. The company has successfully collaborated with over 70 global clients, showcasing the commercial viability of its services. Avantium focuses on two primary areas: developing biofuels and bio-based chemicals, as well as new crystal forms of patented drugs. Its business model includes a strong emphasis on expanding its patent portfolio and establishing partnerships that add value. Additionally, Avantium operates through segments such as R&D Solutions, Renewable Chemistries, and Renewable Polymers, with the R&D Solutions segment generating the majority of its revenue. The company is supported by a team of experts in various fields, including catalysis, organic chemistry, and software development, who work closely with partner organizations to drive innovation in sustainable chemistry.

Sequana Medical

Series C in 2014
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.

FRX Innovations

Series C in 2014
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

Green Biologics

Series B in 2013
Green Biologics is a revenue generating industrial biotech company based in Oxfordshire aiming to become the world's leading supplier of advanced fermentation technologies for conversion of biomass to renewable fuels and chemicals.

iSTAR Medical

Series A in 2013
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Trod Medical

Series B in 2013
Trod Medical S.A. is a medical equipment and surgical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and a presence in the Tampa Bay area, USA. The company specializes in developing innovative ablation technologies, particularly focusing on radiofrequency (RF) ablation devices. Trod Medical's flagship product, the EncageTM, is a disruptive percutaneous RF device that enables precise tissue ablation, significantly reducing collateral damage—a critical concern in treatments for conditions such as prostate cancer. With prostate cancer being one of the most prevalent cancers, affecting approximately 240,000 new patients annually in the United States, Trod Medical's technology addresses the limitations of conventional treatments that often lead to severe side effects, including erectile dysfunction and urinary incontinence. The company aims to enhance patient outcomes through its advanced medical devices designed for the focal ablation of soft tissues.

NGDATA

Series A in 2013
NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.

Green Biologics

Venture Round in 2013
Green Biologics is a revenue generating industrial biotech company based in Oxfordshire aiming to become the world's leading supplier of advanced fermentation technologies for conversion of biomass to renewable fuels and chemicals.

Mainstay Medical

Series B in 2012
Mainstay Medical Holdings plc is a medical device company based in Dublin, Ireland, with operations in the United States and Australia. Founded in 2008, the company is dedicated to developing and commercializing innovative therapies for chronic low back pain, a condition affecting a significant portion of the population. Its flagship product, ReActiv8, is an implantable neurostimulation system that aims to restore control to the muscles stabilizing the lumbar spine. Mainstay Medical collaborates with scientists and clinical experts to address the unmet needs of patients suffering from debilitating back pain, combining expertise in engineering and clinical development to deliver effective solutions in this challenging medical area.

Metallkraft AS

Acquisition in 2012
Metallkraft AS processes and recovers silicon carbide, polyethylene glycol, and SiSiCar from spent cutting fluid employed in the production of silicon wafers by the solar and integrated circuitry industries. Its products include slurry recovery, SIC, and glycol; and SiSiCar, a silicon carbide.

Green Biologics

Venture Round in 2012
Green Biologics is a revenue generating industrial biotech company based in Oxfordshire aiming to become the world's leading supplier of advanced fermentation technologies for conversion of biomass to renewable fuels and chemicals.

Trinean

Venture Round in 2012
Trinean is a Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level by combining best in class analytical software with a highly standardized read-out platform. Founded in 2006 as a spin-out of the Ghent University, Belgium and Imec Leuven, Belgium, the company commercializes UV/VIS spectrometers for biomolecule quantification. The DropSense™16 and DropSense™96, analyzing up to 16 and 96 samples resp., use microfluidic chips for standardized sample analysis (DropPlates™ and Slides). The Trinean platform is complemented with a software toolbox for improved data interpretation and lab-automation.

NovoPolymers

Venture Round in 2012
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.
Liquidity manufactures breakthrough water purification cartridges, based on revolutionary membrane nanoscience, to solve the world's potable water needs. Pour any non-salt water through their cartridge and drink it safely. It's that simple. No chemicals, no power nor pressure. Their product will save millions of lives currently lost to preventable waterborne diseases.

EpiGan

Venture Round in 2011
EpiGaN, a Leuven, Belgium-based company that develops Gallium Nitride on Silicon (GaN) on-silicon wafers...

FRX Innovations

Series B in 2011
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

Nexstim

Venture Round in 2011
Nexstim Plc is a neuromodulation company based in Helsinki, Finland, that develops and markets non-invasive brain stimulation technologies. The company specializes in image-guided transcranial magnetic stimulation (TMS) through its proprietary SmartFocus technology, which features 3D navigation for both therapeutic and diagnostic purposes. Nexstim offers the NBT system, designed to treat major depressive disorder and chronic neuropathic pain, as well as the NBS system, which is utilized for pre-surgical mapping of the brain's speech and motor cortices. Primarily, the NBS systems are sold to universities and teaching hospitals. Founded in 2000, Nexstim aims to enhance the quality of life for patients with significant unmet clinical needs through its innovative approaches to brain therapy.

Sequana Medical

Series B in 2011
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.

NovoPolymers

Series B in 2011
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Ensartech

Venture Round in 2011
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

Ducatt

Venture Round in 2010
Ducatt NV, a Belgium-based solar-glass start-up.

Green Biologics

Series B in 2010
Green Biologics is a revenue generating industrial biotech company based in Oxfordshire aiming to become the world's leading supplier of advanced fermentation technologies for conversion of biomass to renewable fuels and chemicals.

Anteryon

Venture Round in 2010
Anteryon B.V. designs and manufactures high-tech optical solutions. It offers micro-optics solutions, such as camera modules, stacked wafers, and lens wafers; lenses, including aspheric lenses, lens arrays, free form lenses, and lenticulars; lasers that comprise diode laser modules, fiber collimators, and assemblies; and planar optics, which include substrates, precision optics, optical coatings, and powder blasting. The company serves semiconductor lithography, measurement equipment, data storage, and optical media markets. Anteryon B.V. was formerly known as Philips Optics and changed its name to Anteryon B.V. in 2006. The company was founded in 1943 and is based in Eindhoven, the Netherlands. Anteryon B.V. operates as a subsidiary of Anteryon International B.V.

FRX Innovations

Series A in 2009
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

NovoPolymers

Series A in 2009
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Neosens

Series B in 2009
Neosens SA engages in the design and development of sensor solutions and technologies to monitor and control water and industrial liquids. It offers sensors that monitor the presence of dissolved oxygen in liquid environments; and fouling systems for continuous fouling monitoring in liquid environments. The company’s solutions are used in various water and environmental applications, including cooling systems, heat exchangers, potable water, ultra-pure waters, and industrial boilers, as well as in food and beverage, pharmaceutical, pulp and paper, oil, gas, and petrochemical industries. The company was founded in 2001 and is based in Labege, France.

Metallkraft AS

Series A in 2008
Metallkraft AS processes and recovers silicon carbide, polyethylene glycol, and SiSiCar from spent cutting fluid employed in the production of silicon wafers by the solar and integrated circuitry industries. Its products include slurry recovery, SIC, and glycol; and SiSiCar, a silicon carbide.

Avantium

Venture Round in 2008
Avantium is a technology company based in Amsterdam, specializing in advanced high-throughput research and development for the energy, chemicals, and pharmaceutical sectors. It employs proprietary technology that accelerates and reduces the costs associated with developing new products and processes. Avantium's innovative approach to experiment design and data analysis enhances its success rate in delivering effective solutions. The company has successfully collaborated with over 70 global clients, showcasing the commercial viability of its services. Avantium focuses on two primary areas: developing biofuels and bio-based chemicals, as well as new crystal forms of patented drugs. Its business model includes a strong emphasis on expanding its patent portfolio and establishing partnerships that add value. Additionally, Avantium operates through segments such as R&D Solutions, Renewable Chemistries, and Renewable Polymers, with the R&D Solutions segment generating the majority of its revenue. The company is supported by a team of experts in various fields, including catalysis, organic chemistry, and software development, who work closely with partner organizations to drive innovation in sustainable chemistry.

Fluxome

Series B in 2008
Fluxome is a global supplier of natural ingredients with beneficial effects to the human health. They believe that their unique technology and their focused efforts towards developing safe and natural nutraceutical ingredients from a secure and renewable source can help make a difference for their customers.

Ensartech

Venture Round in 2008
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

CoreOptics

Venture Round in 2008
CoreOptics is the leading providers of 10G and 40G Distortion Tolerant Transponder Modules and IC solutions for Metro, Regional and Long Haul optical & data networking markets.With a belief that optical communications networks must become open systems that economically transmit information regardless of data rate or fiber types, CoreOptics provides the only field-proven MLSE-based equalization solutions on the market today. This innovative technology helps Tier 1 systems vendors and carriers deploy the next generation of high-performance networks using their existing fiber infrastructure. CoreOptics' 10G and 40G Distortion Tolerant Transponder Modules eliminate the need for Optical Compensators and the respective Second Stage Amplifiers, allowing customers to reduce their first-in deployment cost by up to 30%.

iNEWiT

Venture Round in 2008
iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for the business-to-consumer markets. The company was founded in 2005 and is based in Mechelen, Belgium

Neosens

Venture Round in 2008
Neosens SA engages in the design and development of sensor solutions and technologies to monitor and control water and industrial liquids. It offers sensors that monitor the presence of dissolved oxygen in liquid environments; and fouling systems for continuous fouling monitoring in liquid environments. The company’s solutions are used in various water and environmental applications, including cooling systems, heat exchangers, potable water, ultra-pure waters, and industrial boilers, as well as in food and beverage, pharmaceutical, pulp and paper, oil, gas, and petrochemical industries. The company was founded in 2001 and is based in Labege, France.

Certess

Venture Round in 2007
Certess is the only electronic design automation (EDA) company providing functional qualification products for companies that create and integrate complex design blocks or intellectual property (IP). Most advanced functional verification teams currently use a combination of techniques to gain visibility into the question of verification quality only to constantly fall short of the ability to truly qualify designs. Although verification engineers have dedicated tools and methodologies for verification quality improvement, functional logic errors still remain the largest causes of chip respins. They provide design and verification engineers with an objective way to evaluate and improve the completeness of the verification environment, resulting in a shorter and more predictable process to integrate SoC designs and ensure high quality designs. The company was incorporated in 2005 and was based in Campbell, California. In March 2009, Certess was acquired by SpringSoft, LLC.

Mendel

Series D in 2007
Mendel Biotechnology, Inc. is a plant biotechnology company based in Hayward, California, founded in 1997. The company focuses on developing genetic and chemical solutions aimed at enhancing agricultural productivity. Its offerings include products designed to improve biofuel feedstocks, yield enhancement, drought and freezing tolerance, disease resistance, nutrient use efficiency, and cold germination. Mendel has established strategic partnerships with prominent organizations such as Monsanto, BP, and Bayer CropScience, and it operates across multiple regions, including the United States, Europe, and China.

MAPPER Lithography

Series B in 2007
MAPPER Lithography B.V. develops a maskless lithography infrastructure for the semiconductor industry. It offers tools that use multiple e-beam technology for manufacturing semiconductors. The company’s technology is used for making chips without a mask and using electron beams. MAPPER Lithography B.V. was founded in 2000 and is based in Delft, the Netherlands. The company has a manufacturing facility in Moscow, Russian Federation.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in delivering secure and efficient payment processing solutions for financial institutions. Its Open Payment Framework (OPF) is designed to enhance internal payment processing while offering clients faster payment services accompanied by comprehensive information. The OPF operates on a Service-Oriented Architecture (SOA), allowing institutions to process various payment types through a centralized payments engine that leverages a library of reusable business services. By enabling the integration of new service models with existing infrastructures, Clear2Pay helps banks protect their prior investments while facilitating a gradual transition to a more modern and efficient payments environment.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Welcome Real Time

Venture Round in 2005
Welcome Real-time S.A. provides credit and debit card acceptance, and payment integrated value-added service solutions for the banks, retailers, merchants, and financial organizations. Its products include XLS Server, which adds EMV capabilities to a bank's payment authorization and processing system; XLS POS that includes software libraries used by POS developers to create full featured payment applications; XLS Card, which includes personalization specifications and card applets used to add payment parameters and data next to EMV risk parameters, and data during the card issuance process; CardCare that provides card activity reporting and card's contents to facilitate cardholder services, such as card replacements and cardholder inquiries through a bank's Website or call centre; and MerchantCare, which provides a bank's merchant services with merchant activity reporting, as well as a view of merchant's transaction activity and payment parameter settings. The company was founded in 1996 and is headquartered in Aix-en-Province, France with additional offices, and research and development facilities in Singapore, Singapore; Madrid, Spain; Miami, Florida; Shanghai, China; and Sao Paulo, Brazil.

TiGenix

Venture Round in 2003
TiGenix NV (TiGenix) and its subsidiaries TiGenix Inc. and TC CEF LLC. is a Belgium-based biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. The Company is exploiting the power of regenerative medicine for the development of durable treatments, validated through controlled clinical studies, for these indications. TiGenix is located in Leuven and was founded as a spin-off of the Catholic University of Leuven and the University of Ghent. TiGenix is developing a portfolio of products that addresses specific musculoskeletal problems. The lead indication among these is cartilage damage, which is a debilitating affliction severely affecting the mobility and functioning of patients. During the fiscal year ended December 31, 2009, the Company acquired Orthomimetics Ltd.

Curl

Series D in 2002
Curl develops and maintains the Curl Rich Internet Application (RIA) platform. The foundational technologies for Curl emerged out of research conducted at the Massachusetts Institute of Technology, and the company's first product was released in 2002. Curl's customer list includes Nissan, Panasonic and Mitsubishi. Curl is a part of an emerging group of technologies referred to as "fit clients." These technologies are a hybrid of Thick Clients (a.k.a. Fat Clients) and Thin Clients (HTML and RIA). Fit clients embrace the local processing and offline capabilities of Thick Clients while providing tooling normally associated with thin-client web applications. Fit Clients can leverage the processing power and disc space of the client machine, but they can also offer more restrictive and secure environments than client/server platforms. Using Curl, developers can implement a new class of complex, business-critical, Web-based applications that cannot easily be developed with Ajax or other smart client technologies. Curl has always provided fit client capabilities and, with a new version announced this month called Nitro, they are available more easily than ever on the desktop. Curl is best choice for enterprises for secure, mission-critical applications that use large data sets and require 3D and 2D rendering, sophisticated data input and visualization.

Equator Technologies

Series D in 2000
Equator Technologies, Inc. is a provider of system-on-a-chip processors for video streaming and image processing applications.